78 related articles for article (PubMed ID: 17548531)
21. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
22. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium.
Song SW; Chang W; Song BW; Song H; Lim S; Kim HJ; Cha MJ; Choi E; Im SH; Chang BC; Chung N; Jang Y; Hwang KC
Stem Cells; 2009 Jun; 27(6):1358-65. PubMed ID: 19489098
[TBL] [Abstract][Full Text] [Related]
23. Histocompatibility testing of cultivated human bone marrow stromal cells - a promising step towards pre-clinical screening for allogeneic stem cell therapy.
Koppula PR; Chelluri LK; Polisetti N; Vemuganti GK
Cell Immunol; 2009; 259(1):61-5. PubMed ID: 19577229
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.
Wu Y; Chen L; Scott PG; Tredget EE
Stem Cells; 2007 Oct; 25(10):2648-59. PubMed ID: 17615264
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging of mesenchymal stem cells labeled with dual (MR and fluorescence) agents in rat spinal cord injury.
Shen J; Zhong XM; Duan XH; Cheng LN; Hong GB; Bi XB; Liu Y
Acad Radiol; 2009 Sep; 16(9):1142-54. PubMed ID: 19660710
[TBL] [Abstract][Full Text] [Related]
26. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart.
Furlani D; Li W; Pittermann E; Klopsch C; Wang L; Knopp A; Jungebluth P; Thedinga E; Havenstein C; Westien I; Ugurlucan M; Li RK; Ma N; Steinhoff G
Cell Transplant; 2009; 18(3):319-31. PubMed ID: 19558780
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model.
Kuo YR; Goto S; Shih HS; Wang FS; Lin CC; Wang CT; Huang EY; Chen CL; Wei FC; Zheng XX; Lee WP
Transplantation; 2009 Jun; 87(12):1769-77. PubMed ID: 19543052
[TBL] [Abstract][Full Text] [Related]
29. Feasibility of a stem cell therapy for intervertebral disc degeneration.
Sobajima S; Vadala G; Shimer A; Kim JS; Gilbertson LG; Kang JD
Spine J; 2008; 8(6):888-96. PubMed ID: 18082460
[TBL] [Abstract][Full Text] [Related]
30. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice.
Morigi M; Introna M; Imberti B; Corna D; Abbate M; Rota C; Rottoli D; Benigni A; Perico N; Zoja C; Rambaldi A; Remuzzi A; Remuzzi G
Stem Cells; 2008 Aug; 26(8):2075-82. PubMed ID: 18499895
[TBL] [Abstract][Full Text] [Related]
31. Antitumoral activity and osteogenic potential of mesenchymal stem cells expressing the urokinase-type plasminogen antagonist amino-terminal fragment in a murine model of osteolytic tumor.
Fritz V; Noël D; Bouquet C; Opolon P; Voide R; Apparailly F; Louis-Plence P; Bouffi C; Drissi H; Xie C; Perricaudet M; Müller R; Schwarz E; Jorgensen C
Stem Cells; 2008 Nov; 26(11):2981-90. PubMed ID: 18757301
[TBL] [Abstract][Full Text] [Related]
32. Opportunities and challenges for mesenchymal stem cell-mediated heart repair.
Atsma DE; Fibbe WE; Rabelink TJ
Curr Opin Lipidol; 2007 Dec; 18(6):645-9. PubMed ID: 17993810
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells for cardiac regenerative therapy.
Schuleri KH; Boyle AJ; Hare JM
Handb Exp Pharmacol; 2007; (180):195-218. PubMed ID: 17554510
[TBL] [Abstract][Full Text] [Related]
34. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
35. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation.
Comoli P; Ginevri F; Maccario R; Avanzini MA; Marconi M; Groff A; Cometa A; Cioni M; Porretti L; Barberi W; Frassoni F; Locatelli F
Nephrol Dial Transplant; 2008 Apr; 23(4):1196-202. PubMed ID: 18029377
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair.
Wei HJ; Chen CH; Lee WY; Chiu I; Hwang SM; Lin WW; Huang CC; Yeh YC; Chang Y; Sung HW
Biomaterials; 2008 Sep; 29(26):3547-56. PubMed ID: 18538386
[TBL] [Abstract][Full Text] [Related]
37. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.
Phinney DG; Prockop DJ
Stem Cells; 2007 Nov; 25(11):2896-902. PubMed ID: 17901396
[TBL] [Abstract][Full Text] [Related]
38. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
[TBL] [Abstract][Full Text] [Related]
39. Combining angiogenic gene and stem cell therapies for myocardial infarction.
Pons J; Huang Y; Takagawa J; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW; Su H
J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
[TBL] [Abstract][Full Text] [Related]
40. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
